Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
HIV Medicine|July 30, 2010
The evolving burden of HIV infection compared with other chronic diseases in northern ItalyM Magoni, C Scarcella, F Vassallo, et al.
Journal of Clinical Laboratory Analysis|May 8, 2000
Decrease of HCVRNA after three days of daily interferon treatment is predictive of the virological response at one monthA Magalini, M Puoti, V Putzolu, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 18, 2015
Use of efavirenz or atazanavir/ritonavir is associated with better clinical outcomes of HAART compared to other protease inhibitors: routine evidence from the Italian MASTER CohortM C Postorino, M Prosperi, E Quiros-Roldan, et al.
HIV Medicine|July 16, 2003
Characterization of viro-immunological responses in a closely followed cohort of heavily pretreated patients: evidence from the GenPheRex StudyC Torti, E Quiros-Roldan, L Scudeller, et al.
Epidemiology and Infection|January 30, 2010
Heterogeneity and penetration of HIV-1 non-subtype B viruses in an Italian province: public health implicationsC Torti, G Lapadula, I Izzo, et al.
AIDS Patient Care and Stds|January 7, 2005
Lopinavir plasma levels in salvage regimes by a population of highly active antiretroviral therapy-treated HIV-1-positive patientsC Torti, E Quiros-Roldan, V Tirelli, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 10, 2004
Prevalence of drug resistance and newly recognised treatment-related substitutions in the HIV-1 reverse transcriptase and protease genes from HIV-positive patients naïve for anti-retroviralsC Torti, L Bono, F Gargiulo, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 11, 2001
Pilot dose-finding trial on interferon alpha in combination with ribavirin for the treatment of chronic hepatitis C in patients not responding to interferon aloneM Puoti, G P Cadeo, V Putzolu, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 17, 2011
Factors influencing the normalization of CD4+ T-cell count, percentage and CD4+/CD8+ T-cell ratio in HIV-infected patients on long-term suppressive antiretroviral therapyC Torti, M Prosperi, D Motta, et al.
AIDS (London, England)|March 15, 2019
Switch to dolutegravir and unboosted atazanavir in HIV-1 infected patients with undetectable viral load and long exposure to antiretroviral therapyAntonella Castagna, Stefano Rusconi, Roberto Gulminetti, et al.
Pageof 4